Swiss National Bank Nektar Therapeutics Transaction History

Swiss National Bank

$146 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.64 - $3.15 $29,952 - $147,420	-46,800 Reduced 10.34%	405,700 $283,000
Q4 2022 Feb 08, 2023	BUY	$2.03 - $4.28 $21,923 - $46,224	10,800 Added 2.45%	452,500 $1.02 Million
Q3 2022 Nov 09, 2022	BUY	$3.04 - $5.14 $16,112 - $27,242	5,300 Added 1.21%	441,700 $1.41 Million
Q1 2022 May 09, 2022	BUY	$4.16 - $13.72 $133,120 - $439,040	32,000 Added 7.91%	436,400 $2.35 Million
Q4 2021 Feb 08, 2022	BUY	$10.83 - $18.41 $17,328 - $29,456	1,600 Added 0.4%	404,400 $5.46 Million
Q3 2021 Nov 08, 2021	BUY	$13.07 - $18.84 $96,718 - $139,416	7,400 Added 1.87%	402,800 $7.23 Million
Q2 2021 Aug 06, 2021	SELL	$16.52 - $20.4 $237,888 - $293,760	-14,400 Reduced 3.51%	395,400 $6.79 Million
Q1 2021 May 07, 2021	BUY	$16.56 - $25.46 $87,768 - $134,938	5,300 Added 1.31%	409,800 $8.2 Million
Q4 2020 Feb 05, 2021	BUY	$15.77 - $19.03 $17,347 - $20,933	1,100 Added 0.27%	404,500 $6.88 Million
Q3 2020 Nov 09, 2020	BUY	$16.59 - $24.79 $177,513 - $265,253	10,700 Added 2.72%	403,400 $6.69 Million
Q2 2020 Aug 05, 2020	BUY	$16.86 - $23.44 $868,290 - $1.21 Million	51,500 Added 15.09%	392,700 $9.1 Million
Q1 2020 May 08, 2020	BUY	$14.47 - $27.96 $63,248 - $122,213	4,371 Added 1.3%	341,200 $6.09 Million
Q4 2019 Feb 06, 2020	SELL	$15.87 - $23.12 $3.79 Million - $5.52 Million	-238,800 Reduced 41.49%	336,829 $7.27 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $206,792 - $443,545	12,229 Added 2.17%	575,629 $10.5 Million
Q2 2019 Aug 02, 2019	SELL	$31.0 - $36.3 $437,100 - $511,829	-14,100 Reduced 2.44%	563,400 $20 Million
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $521,070 - $764,775	16,500 Added 2.94%	577,500 $19.4 Million
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $419,934 - $781,770	13,800 Added 2.52%	561,000 $18.4 Million
Q3 2018 Nov 08, 2018	BUY	$46.46 - $68.49 $720,130 - $1.06 Million	15,500 Added 2.92%	547,200 $33.4 Million
Q2 2018 Aug 09, 2018	BUY	$46.25 - $104.45 $11.9 Million - $26.8 Million	256,700 Added 93.35%	531,700 $26 Million
Q1 2018 May 04, 2018	BUY	$57.4 - $108.44 $499,380 - $943,428	8,700 Added 3.27%	275,000 $29.2 Million
Q4 2017 Feb 07, 2018	BUY	$23.02 - $60.5 $156,536 - $411,400	6,800 Added 2.62%	266,300 $15.9 Million
Q3 2017 Nov 03, 2017	BUY	$17.79 - $24.0 $4.62 Million - $6.23 Million	259,500	259,500 $6.23 Million

Others Institutions Holding NKTR

# of Institutions

152

Shares Held

131M

Call Options Held

92.7K

Put Options Held

4.9K

Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.3M
Shares

$11.5 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.67M
Shares

$8.99 Million
0.14% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

7.81M
Shares

$7.26 Million
0.37% of portfolio
Acadian Asset Management LLC Boston, MA

7.2M
Shares

$6.7 Million
0.02% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account